Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Walters

Showing results (681-690 of 725) with videos related to

Pageof 73
Sort By:
Nature Genetics|May 16, 2019
Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia riskLaura M Huckins, Amanda Dobbyn, Douglas M Ruderfer, et al.
Neurology|January 14, 2025
Antiseizure Medications in Poststroke Seizures: A Systematic Review and Network Meta-AnalysisShubham Misra, Selena Wang, Terence J Quinn, et al.
BMC Psychiatry|November 19, 2022
Patient characteristics associated with retrospectively self-reported treatment outcomes following psychological therapy for anxiety or depressive disorders - a cohort of GLAD study participantsChristopher Rayner, Jonathan R I Coleman, Megan Skelton, et al.
Schizophrenia Research|March 31, 2023
Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort studyEdward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Journal of Anxiety Disorders|November 14, 2021
Comparison of symptom-based versus self-reported diagnostic measures of anxiety and depression disorders in the GLAD and COPING cohortsMolly R Davies, Joshua E J Buckman, Brett N Adey, et al.
Molecular Psychiatry|November 13, 2013
Evidence that duplications of 22q11.2 protect against schizophreniaE Rees, G Kirov, A Sanders, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Molecular Psychiatry|June 29, 2026
Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorderAbigail R Ter Kuile, Brittany L Mitchell, Sang Hyuck Lee, et al.
Neurosurgical Review|September 23, 2025
Medical student perceptions and career intentions toward neurosurgery: results from an international multicentre studyMohammad Ashraf, Hassan Ismahel, Gemma Learmonth, et al.
Pageof 73

Showing results (681-690 of 725) with videos related to

Sort By:
Pageof 73
Nature Genetics|May 16, 2019
Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia riskLaura M Huckins, Amanda Dobbyn, Douglas M Ruderfer, et al.
Neurology|January 14, 2025
Antiseizure Medications in Poststroke Seizures: A Systematic Review and Network Meta-AnalysisShubham Misra, Selena Wang, Terence J Quinn, et al.
BMC Psychiatry|November 19, 2022
Patient characteristics associated with retrospectively self-reported treatment outcomes following psychological therapy for anxiety or depressive disorders - a cohort of GLAD study participantsChristopher Rayner, Jonathan R I Coleman, Megan Skelton, et al.
Schizophrenia Research|March 31, 2023
Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort studyEdward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Journal of Anxiety Disorders|November 14, 2021
Comparison of symptom-based versus self-reported diagnostic measures of anxiety and depression disorders in the GLAD and COPING cohortsMolly R Davies, Joshua E J Buckman, Brett N Adey, et al.
Molecular Psychiatry|November 13, 2013
Evidence that duplications of 22q11.2 protect against schizophreniaE Rees, G Kirov, A Sanders, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Molecular Psychiatry|June 29, 2026
Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorderAbigail R Ter Kuile, Brittany L Mitchell, Sang Hyuck Lee, et al.
Neurosurgical Review|September 23, 2025
Medical student perceptions and career intentions toward neurosurgery: results from an international multicentre studyMohammad Ashraf, Hassan Ismahel, Gemma Learmonth, et al.
Pageof 73